EX-99.1 2 rdy0759_ex99-1.htm EXHIBIT 99-1

 

Exhibit 99.1

 

Dr. Reddy's Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills

Hyderabad – 500 034, Telangana,

India.

CIN: L85195TG1984PLC004507

 

Tel:      + 91 40 4900 2900

Fax:     + 91 40 4900 2999

Email:  mail@drreddys.com

www.drreddys.com

 

May 28, 2025

 

To,

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd (Stock Code: DRREDDY)

 

Dear Sir/Madam,

 

Sub: Copy of Newspaper Publication regarding transfer of unclaimed dividend and underlying equity shares to Investor Education and Protection Fund (IEPF)

 

Please find enclosed a copy of the Notice published on May 28, 2025 in Business Standard and Nava Telangana pertaining to unclaimed dividend and equity shares which are liable to be transferred to the IEPF pursuant to Section 124(6) of the Companies Act, 2013 and rules thereunder.

 

This is for your information and records.

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited


K Randhir Singh

Company Secretary, Compliance Officer and Head-CSR

 

Encl: as above